Positron Emission Tomography Scanners

Global Positron Emission Tomography Scanners Market to Reach US$3.1 Billion by 2030

The global market for Positron Emission Tomography Scanners estimated at US$2.3 Billion in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Full Ring PET Scanner, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Partial Ring PET Scanner segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$637.1 Million While China is Forecast to Grow at 8.6% CAGR

The Positron Emission Tomography Scanners market in the U.S. is estimated at US$637.1 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$646.1 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global “Positron Emission Tomography (PET) Scanners” Market – Key Trends & Drivers Summarized

Can PET Scanning Transform the Next Era of Diagnostic Precision?
Positron Emission Tomography (PET) scanners are at the forefront of precision imaging, enabling clinicians to visualize metabolic and physiological functions in real-time. Unlike traditional CT or MRI, PET imaging provides insights at the cellular and molecular levels, making it indispensable for detecting early-stage cancers, neurological disorders, and cardiovascular anomalies. With rising incidences of diseases like Alzheimer’s and lymphoma, PET scanners are becoming a cornerstone in both diagnostics and treatment planning. These machines are often integrated with CT or MRI systems (PET/CT or PET/MRI), offering hybrid imaging capabilities that enhance diagnostic accuracy and reduce patient exposure to multiple procedures. The ability of PET to assess biological activity allows for targeted therapies and personalized medicine — both rapidly growing fields in oncology and neurology. Recent advancements have enabled the use of novel radiotracers, expanding the range of detectable conditions. Furthermore, as healthcare shifts from reactive to preventative models, PET scanners are finding increased usage in health screening programs and clinical trials. Their growing role in drug development, especially for immunotherapy and neuropharmacology, underscores their diagnostic and prognostic potential.

How Is the Global PET Scanner Market Evolving Across Regions?
The global PET scanner market is undergoing robust expansion, driven by technological improvements, rising chronic disease prevalence, and expanding access to advanced diagnostics. North America holds the largest share, due to the presence of sophisticated healthcare infrastructure, supportive reimbursement policies, and high awareness of early diagnostics. Europe follows closely, with growing adoption in Germany, France, and the UK, where public health systems are increasingly investing in molecular imaging for cancer and brain disorders. Meanwhile, the Asia-Pacific region is witnessing the fastest growth, led by China, Japan, and India, where rising healthcare expenditure, aging populations, and increasing cancer cases are catalyzing market expansion. Government initiatives in these regions, including subsidies for diagnostic imaging and public-private partnerships, are improving access to PET facilities. In emerging markets, mobile PET units and public diagnostic centers are helping bridge the urban-rural imaging gap. Additionally, global diagnostic chains are expanding their reach in tier-2 and tier-3 cities, making PET imaging more accessible. As global awareness around early detection and personalized medicine rises, PET scanner installations are expected to increase steadily in both developed and developing economies.

What Technological Breakthroughs Are Defining the Future of PET Imaging?
Technology is rapidly reshaping the capabilities and applications of PET scanners. Modern scanners now utilize digital detectors instead of traditional photomultiplier tubes, offering higher resolution, faster scan times, and reduced radiation doses. Time-of-flight (TOF) PET technology has dramatically improved image clarity and lesion detectability by accurately measuring the arrival time of photons. Integration with artificial intelligence (AI) and machine learning is enabling automated image interpretation, anomaly detection, and improved workflow efficiency. AI also supports radiomics — extracting large amounts of quantitative data from images to predict outcomes and guide treatment. Radiotracer development is another frontier, with newer agents targeting tau proteins in Alzheimer’s, amyloid plaques, prostate-specific membrane antigens (PSMA), and fibroblast activation proteins (FAPs) in various cancers. These specialized tracers allow more targeted disease detection and are transforming PET into a tool for theranostics — combining therapy and diagnostics. Portable and compact PET scanners, especially for brain imaging, are also being developed for use in emergency and outpatient settings. Meanwhile, innovations in hybrid modalities, such as PET/MRI, are facilitating comprehensive diagnostics with reduced scanning time and patient discomfort. These breakthroughs are making PET imaging more powerful, patient-friendly, and accessible across healthcare tiers.

The Growth in the PET Scanners Market Is Driven by Several Factors…
The growth in the PET scanners market is driven by several factors directly linked to advanced diagnostics, evolving healthcare models, and innovation in both hardware and tracers. Rising prevalence of chronic and lifestyle-related diseases — especially cancer, neurological conditions, and cardiac disorders — is leading to increased demand for early and precise diagnosis. The expansion of personalized medicine and targeted therapies relies heavily on PET imaging to monitor drug efficacy and tumor response. Technological innovations such as digital PET, AI-driven analytics, and time-of-flight imaging are enhancing image resolution and reducing scan duration, improving patient throughput and diagnostic confidence. The development of novel radiopharmaceuticals tailored to specific disease markers is expanding clinical applications and driving repeat PET procedures. On the demand side, growing patient awareness, broader insurance coverage, and the integration of PET into routine oncology pathways are increasing scan volumes. The rise of clinical research and pharma-sponsored trials also necessitates PET capabilities for biomarker-based assessments. Finally, infrastructure investment — including mobile PET units and scalable imaging suites — is helping meet rising demand in both urban hospitals and rural outreach programs. These aligned drivers are positioning PET scanners as indispensable tools in the future of predictive and precision medicine.

SCOPE OF STUDY:

The report analyzes the Positron Emission Tomography Scanners market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Full Ring PET Scanner, Partial Ring PET Scanner); Application (Oncology, Cardiology, Neurology, Other Applications); Detector Type (Bismuth Germanium Oxide, Lutetium Oxyorthosilicate, Gadolinium Oxyorthosilicate, Lutetium Fine Silicate, Lutetium Yttrium Orthosilicate); End-User (Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes, Other End-Users)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Agfa-Gevaert
• Basda Medical
• Canon Medical Systems Corporation
• CMR Naviscan
• Cubresa Inc.
• GE Healthcare
• Hitachi, Ltd.
• Koninklijke Philips N.V.
• Mediso Ltd.
• MinFound Medical Systems
• MR Solutions
• Neusoft Medical Systems
• Oncovision
• Planmeca Oy
• Positron Corporation
• Shimadzu Corporation
• Siemens Healthineers AG
• Spectrum Dynamics Medical
• Toshiba Medical Systems Corporation
• United Imaging Healthcare Co., Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.